September 11, 2013
An Illinois federal judge tossed a pair of shareholder suits Wednesday over statements BioSante Pharmaceuticals Inc. made about clinical trials for an experimental women's libido drug, finding that neither suit clearly spelled out what the company had allegedly done wrong.
February 06, 2012
An investor hit BioSante Pharmaceuticals Inc. with a securities fraud class action Friday in Illinois claiming CEO Stephen Simes told tall tales about how an experimental women's libido drug was bound for torrid sales before clinical results threw cold water on shareholders.